Tonix Pharmaceuticals Holding Corp.
Prognozy (mln)
| Okres |
2024-12-31 |
2025-12-31 |
2026-12-31 |
2027-12-31 |
2028-12-31 |
| Przychód (średnia) |
12.80 |
11.99 |
81.70 |
110.83 |
657.95 |
| Przychód Δ r/r |
0.00% |
-6.30% |
581.23% |
35.65% |
493.68% |
| Przychód (min) |
11.81 |
7.68 |
31.30 |
52.39 |
311.02 |
| Przychód (max) |
13.79 |
16.30 |
166.10 |
205.40 |
1,219.40 |
| EBITDA (średnia) |
-7.68 |
-7.20 |
-49.02 |
-66.50 |
-394.77 |
| EBIT (średnia) |
-7.68 |
-7.20 |
-49.02 |
-66.50 |
-394.77 |
| EBIT % |
-60.00% |
-60.00% |
-60.00% |
-60.00% |
-60.00% |
| Zysk netto (średni) |
-131.93 |
-27.45 |
-13.75 |
-0.82 |
5.46 |
| Zysk netto % |
-1030.67% |
-228.87% |
-16.83% |
-0.74% |
0.83% |
| EPS (średnia) |
-113.50 |
-12.13 |
-6.08 |
-0.30 |
2.41 |
| Liczba analityków (Przychody) |
2 |
2 |
3 |
2 |
1 |
| Liczba analityków (EPS) |
1 |
1 |
2 |
1 |
1 |
| symbol |
TNXP |
TNXP |
TNXP |
TNXP |
TNXP |